Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


Assay co-developed with Merck for detection of KRAS mutations, operating directly on 1 ml blood plasma.

Biocartis Group, an innovative molecular diagnostics company, announces the launch of its second liquid biopsy assay, the Idylla™ ctKRAS Mutation Assay (Research Use Only, RUO), which was developed in partnership with the leading science and technology company Merck1 on Biocartis’ molecular diagnostics platform Idylla™.

Read more ...

Ahead of the inaugural MediSens clinical imaging technology conference in London (12-14 December), we interview our guest speakers and advisory board members, industry professionals with profound experience of the technologies deployed in medical imaging. Jerôme Mouly serves as a Technology & Market Analyst specialized in microtechnologies for biomedical & medical imaging applications at Yole Développement.

Read more ...

Researchers have been working on a new skin patch that tests perspiration for its biochemical components, and beams the results to your phone.While this sounds a lot like other fitness trackers, this is on another level. Just a bit bigger than a quarter, this smart sticker adheres to even the sweatiest of sports participants and exercisers.

Read more ...

Scientists have used Oxford Nanopore’s technology to sequence a whole human genome for the first time ever. The small portable device is challenging the technology of big players like Illumina.

Read more ...

Boston Scientific announced the close of its acquisition of EndoChoice. With the completion of the acquisition, EndoChoice will become part of the Boston Scientific Endoscopy business. EndoChoice is an Alpharetta, Georgia based company focused on the development and commercialization of infection control products, pathology services and single-use devices for specialists treating a wide range of gastrointestinal (GI) conditions.

Read more ...

The new technology allows more precise control and manipulation of cell culture environments, converting microscopes into powerful, state-of-the-art tool for live cell imaging. Merck, a science and technology company, has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging.

The system converts laboratory microscopes into powerful tools for live cell imaging to more effectively perform in-depth analysis of cellular mechanisms and behavior in a live environment.

Read more ...

Upcoming Events

> 4th Advanced Technology Workshop on Microelectronics, Systems and Packaging for Medical Applications
(December 7 - December 8, France, Lyon)

> Medisens 2016
(December 13 - December 14, London, UK)